Ipratropium bromide hydrofluoroalkane inhalation aerosol is safe and effective in patients with COPD. [electronic resource]
Producer: 20011204Description: 1253-61 p. digitalISSN:- 0012-3692
- Adult
- Aerosol Propellants -- administration & dosage
- Aged
- Aged, 80 and over
- Airway Resistance -- drug effects
- Chlorofluorocarbons -- adverse effects
- Double-Blind Method
- Female
- Forced Expiratory Volume -- drug effects
- Humans
- Hydrocarbons, Fluorinated -- adverse effects
- Ipratropium -- administration & dosage
- Male
- Middle Aged
- Nebulizers and Vaporizers
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.